Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.
Sector: Services-Testing Laboratories
Industry: Medical - Diagnostics & Research
Hypha Labs, Inc.
OTC:FUNIHealthcare · Medical - Diagnostics & Research
+0.00%$0.0020
Prev close$0.00200.00%Open$0.00200.00%Now$0.0020
Mkt Cap$328K
EV-
Float150.57M
O/S163.9M
VOL3K sh
$ Vol$6
RVOL0.03×
Inst Own-
Net Cash/Sh-
Dilution
MCap$328KFloat150.57MO/S163.9M
Dilution
Hypha Labs, Inc. (FUNI) dilution facts from SEC filings
Snapshot as of Jun 30, 2026, built from 5 SEC filings.
- Shelf registration
- None on file in the filings reviewed
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 7 warrant series recorded as outstanding
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.